Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
Linked as:
Extract
Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FC 320
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- Stone v. Canada (Attorney General), (2012) 404 F.T.R. 104 (FC)
- Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
- Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)
